2023-03-13T19:47:19Z
The Alzheimer’s drug Leqembi is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout via REUTERS
Eisai Co Ltd said on Monday, that the U.S. Veterans’ Health Administration (VHA) is providing coverage of its treatment Leqembi to veterans living with early stages of Alzheimer’s disease.